130 related articles for article (PubMed ID: 7862905)
1. Platelet 5-HT uptake sites, labelled with [3H] paroxetine, in controls and depressed patients before and after treatment with fluoxetine or lofepramine.
Lawrence KM; Katona CL; Abou-Saleh MT; Robertson MM; Nairac BL; Edwards DR; Lock T; Burns RA; Harrison DA; Horton RW
Psychopharmacology (Berl); 1994 Jun; 115(1-2):261-4. PubMed ID: 7862905
[TBL] [Abstract][Full Text] [Related]
2. Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder.
Bakish D; Cavazzoni P; Chudzik J; Ravindran A; Hrdina PD
Biol Psychiatry; 1997 Jan; 41(2):184-90. PubMed ID: 9018388
[TBL] [Abstract][Full Text] [Related]
3. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
Lawrence KM; Falkowski J; Jacobson RR; Horton RW
Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
[TBL] [Abstract][Full Text] [Related]
4. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment.
Hrdina PD; Bakish D; Ravindran A; Chudzik J; Cavazzoni P; Lapierre YD
Psychiatry Res; 1997 Feb; 66(2-3):73-85. PubMed ID: 9075272
[TBL] [Abstract][Full Text] [Related]
5. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
[TBL] [Abstract][Full Text] [Related]
6. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
[TBL] [Abstract][Full Text] [Related]
7. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
[TBL] [Abstract][Full Text] [Related]
8. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
[TBL] [Abstract][Full Text] [Related]
9. Imipramine binding as a predictor of fluoxetine response in depressed patients.
Castrogiovanni P; Di Muro A; Marazziti D
Neuropsychobiology; 1995; 31(2):64-7. PubMed ID: 7760987
[TBL] [Abstract][Full Text] [Related]
10. 3H-imipramine binding to previously frozen platelet membranes from depressed patients, before and after treatment.
Healy D; Theodorou AE; Whitehouse AM; Lawrence KM; White W; Wilton-Cox H; Kerry SM; Horton RW; Paykel ES
Br J Psychiatry; 1990 Aug; 157():208-15. PubMed ID: 2224370
[TBL] [Abstract][Full Text] [Related]
11. Hypodensity of platelet serotonin uptake sites in posttraumatic stress disorder: associated clinical features.
Fichtner CG; O'Connor FL; Yeoh HC; Arora RC; Crayton JW
Life Sci; 1995; 57(2):PL37-44. PubMed ID: 7603291
[TBL] [Abstract][Full Text] [Related]
12. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
[TBL] [Abstract][Full Text] [Related]
13. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
Arora RC; Meltzer HY
Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243
[TBL] [Abstract][Full Text] [Related]
14. Platelet 3H-paroxetine binding in depressed patients.
D'haenen H; De Waele M; Leysen JE
Psychiatry Res; 1988 Oct; 26(1):11-7. PubMed ID: 2976947
[TBL] [Abstract][Full Text] [Related]
15. Platelet alpha 2-adrenoceptors, defined with agonist and antagonist ligands, in depressed patients, prior to and following treatment.
Theodorou AE; Lawrence KM; Healy D; Whitehouse AM; White W; Wilton-Cox H; Kerry SM; Horton RW; Paykel ES
J Affect Disord; 1991 Nov; 23(3):99-106. PubMed ID: 1685500
[TBL] [Abstract][Full Text] [Related]
16. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine.
Katona CL; Abou-Saleh MT; Harrison DA; Nairac BA; Edwards DR; Lock T; Burns RA; Robertson MM
Br J Psychiatry; 1995 Jan; 166(1):80-6. PubMed ID: 7894881
[TBL] [Abstract][Full Text] [Related]
17. Platelet paroxetine binding and fluoxetine pharmacotherapy in posttraumatic stress disorder: preliminary observations on a possible predictor of clinical treatment response.
Fichtner CG; Arora RC; O'Connor FL; Crayton JW
Life Sci; 1994; 54(3):PL39-44. PubMed ID: 8289574
[TBL] [Abstract][Full Text] [Related]
18. Relationship between parameters of serotonin transport and antidepressant plasma levels or therapeutic response in depressive patients treated with paroxetine and amitriptyline.
Kuhs H; Schlake HP; Rolf LH; Rudolf GA
Acta Psychiatr Scand; 1992 May; 85(5):364-9. PubMed ID: 1534961
[TBL] [Abstract][Full Text] [Related]
19. Significant correlation between 14C-5-HT uptake by and 3H-paroxetine binding to platelets from healthy volunteers.
Maguire K; Tuckwell V; Pereira A; Dean B; Singh B
Biol Psychiatry; 1993 Sep; 34(6):356-60. PubMed ID: 8218602
[TBL] [Abstract][Full Text] [Related]
20. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
Spigset O; Allard P; Mjörndal T
Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
